Showing results (211-220 of 273) with videos related to
Sort By:
Pageof 28
Clinical and Molecular Hepatology|December 15, 2020
Comedications and potential drug-drug interactions with direct-acting antivirals in hepatitis C patients on hemodialysisPo-Yao Hsu, Yu-Ju Wei, Jia-Jung Lee, et al.Plos One|November 20, 2020
The applicability of non-invasive methods for assessing liver fibrosis in hemodialysis patients with chronic hepatitis CJia-Jung Lee, Yu-Ju Wei, Ming-Yen Lin, et al.Journal of Viral Hepatitis|February 3, 2021
Evolutionary seroepidemiology of viral hepatitis and the gap in hepatitis C care cascades among uraemic patients receiving haemodialysis in Taiwan-the Formosa-Like GroupYu-Ju Wei, Po-Yao Hsu, Jia-Jung Lee, et al.American Journal of Cancer Research|January 11, 2023
Artificial intelligence based on serum biomarkers predicts the efficacy of lenvatinib for unresectable hepatocellular carcinomaPo-Yao Hsu, Po-Cheng Liang, Wen-Tsan Chang, et al.Cancer Medicine|November 17, 2021
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levelsPo-Yao Hsu, Tzu-Sheng Cheng, Shih-Chang Chuang, et al.Nature Communications|August 29, 2024
An atlas of the human liver diurnal transcriptome and its perturbation by hepatitis C virus infectionAtish Mukherji, Frank Jühling, Yogy Simanjuntak, et al.Scientific Reports|April 21, 2021
Changing epidemiology and viral interplay of hepatitis B, C and D among injecting drug user-dominant prisoners in TaiwanMing-Ying Lu, Chun-Ting Chen, Yu-Lueng Shih, et al.Hepatology Communications|January 13, 2021
Effects of Cirrhosis and Diagnosis Scenario in Metabolic-Associated Fatty Liver Disease-Related Hepatocellular CarcinomaVincent L Chen, Ming-Lun Yeh, Ju Dong Yang, et al.The Journal of Infectious Diseases|May 17, 2021
Incidences and Determinants of Functional Cure During Entecavir or Tenofovir Disoproxil Fumarate for Chronic Hepatitis BYao-Chun Hsu, Ming-Lun Yeh, Grace Lai-Hung Wong, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|November 2, 2024
Addition of neutrophil-to-lymphocyte ratio to Pre-DAA FIB-4 does not increase prediction value for de novo liver complications in hepatitis CChun-Ming Hong, Tung-Hung Su, Shih-Jer Hsu, et al.Pageof 28